MOREPENLAB2024-04-012024-06-30 MOREPENLAB2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member MOREPENLAB2024-04-012024-06-30in-bse-fin:OneOperatingExpenses02Member MOREPENLAB2024-04-012024-06-30in-bse-fin:OneOperatingExpenses03Member MOREPENLAB2024-04-012024-06-30in-bse-fin:OneOperatingExpenses04Member MOREPENLAB2024-06-30 MOREPENLAB2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500288 MOREPENLAB NOTLISTED Morepen Laboratories Limited Equity 2024-04-01 2025-03-31 2024-08-12 2024-08-07 INR Lakhs First quarter 08:30:00 09:45:00 2024-08-12 2024-08-12 Not applicable Single segment Pharmaceuticals 2024-04-01 2024-06-30 Unaudited Consolidated 4552157000.00 34270000.00 4586427000.00 2350146000.00 559743000.00 -81775000.00 479552000.00 11519000.00 57278000.00 728303000.00 4104766000.00 481661000.00 0.00 481661000.00 119982000.00 0.00 119982000.00 0.00 361679000.00 0.00 0.00 0.00 0.00 361679000.00 25715000.00 387394000.00 0.00 0.00 1022271000.00 2 0.71 0.71 0.00 0.00 0.71 0.71 1.'The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on Aug 12, 2024. A Limited review of the same has been carried out by the Statutory Auditors. 2.'The company has successfully completed a Qualified Institutional Placement (QIP) for Rs. 200 crores on August 5, 2024 by issuing and allotting 3,67,84,991 new Equity shares to the investors. The capital base of company expanded by 6.71% from 51,11,68,708 to 54,79,53,699 3.'Figures for the quarter ended March 31,2024 are the balancing figures between audited figures in respect of the full financial year and the year to date figure up to the third quarter of the relevant financial year which were subjected to Limited Review by the Auditors. 4.'The Company is engaged in the Pharmaceutical Business Segment. Other Expenses 285370000.00 Power & Fuel 92723000.00 Selling & Distribution Expenses 295803000.00 Travelling Expenses 54407000.00 Items that will not be reclassified to profit and loss 34306000.00 34306000.00 8591000.00 0.00